Valproate acts as a broad-spectrum anticonvulsant and mood stabilizer that modulates GABA neurotransmission and reduces neuronal hyperexcitability by inhibiting voltage-gated sodium and calcium channels. In Visual Snow Syndrome, it potentially mitigates cortical hypermetabolism and abnormal neural network synchronization, thereby potentially ameliorating visual disturbances and neurological symptoms associated with the condition.